DNA gyrase as a drug target.
Maxwell
A
A
Department of Biochemistry, University of Leicester, U.K.
D042462:4-Quinolones; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000737:chemistry / Q000494:pharmacology; D003374:Coumarins / Q000737:chemistry / Q000494:pharmacology; D004250:DNA Topoisomerases, Type II / Q000737:chemistry / Q000235:genetics; D004352:Drug Resistance, Microbial / Q000235:genetics; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D005798:Genes, Bacterial; D009154:Mutation; D059005:Topoisomerase II Inhibitors
D042462:4-Quinolones; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D003374:Coumarins; D059005:Topoisomerase II Inhibitors; D004250:DNA Topoisomerases, Type II